NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Secured Loans History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Secured Loans | ₹25 Cr | ₹0.75 Cr | ₹2.07 Cr | ₹3.44 Cr | ₹6.13 Cr |
What is the latest Secured Loans ratio of NGL FINECHEM ?
| Year | Secured Loans |
|---|---|
| Mar2025 | ₹25 Cr |
| Mar2024 | ₹0.75 Cr |
| Mar2023 | ₹2.07 Cr |
| Mar2022 | ₹3.44 Cr |
| Mar2021 | ₹6.13 Cr |
How is Secured Loans of NGL FINECHEM Trending?
| Years | Secured Loans | % Change | |
|---|---|---|---|
| Mar2025 | ₹25 Cr | 3,300.81 | |
| Mar2024 | ₹0.75 Cr | -64.06 | |
| Mar2023 | ₹2.07 Cr | -39.67 | |
| Mar2022 | ₹3.44 Cr | -43.96 | |
| Mar2021 | ₹6.13 Cr | - | |
Compare Secured Loans of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,898.1 Cr | -3% | 13.4% | 197.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,299.0 Cr | 0.5% | 1.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,207.0 Cr | -3.3% | -3.5% | 1.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,721.0 Cr | 4.5% | 2.6% | 42.6% | Stock Analytics | |
| CIPLA | ₹117,420.0 Cr | 2.7% | 2.5% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,876.0 Cr | 6.6% | 4.3% | 1.9% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | -3% |
13.4% |
197.3% |
| SENSEX | -0.1% |
1% |
-5.7% |
You may also like the below Video Courses